JUNS
Jupiter Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.28
+0.61%Leverage
- Debt / equity
- -4.78x
- Net debt / equity
- -0.62x
- Debt / assets
- 0.47x
- Debt / EBITDA
- -0.18x
- Net debt / EBITDA
- -0.02x
Liquidity & coverage
- Current ratio
- 0.66x
- Quick ratio
- 0.62x
- Cash ratio
- 0.39x
- Interest coverage
- -47.42x
- EBITDA / interest
- -45.85x
- Working capital
- -$1.3M
Cash & dividend
- FCF / debt
- -4.14x
- Cash flow / debt
- -4.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026